Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

IFN-gamma regulates the immunogenicity of target cells by increasing their expression of HLA class I molecules. This facilitates the T cell receptor-mediated recognition by CD8(+) T cells but decreases target cell sensitivity to lysis by NK cells due to engagement of inhibitory NK receptors. In this study, short-term tumor cell lines from patients with advanced ovarian carcinomas were established. We demonstrate the paradoxical finding that IFN-gamma treatment of these short-term ovarian carcinoma cell lines (OVACs) resulted in resistance of tumor cells to lysis by peptide- and allospecific CD8(+) T cells. Blocking experiments revealed that this phenomenon was dependent on enhanced inhibitory signalling via CD94/NKG2A receptors expressed on the effector cells. This was associated with increased expression of HLA-E mRNA and HLA-G at the protein level in IFN-gamma-treated OVACs. Furthermore, pulsing of untreated OVACs with the leader sequence peptide of HLA-G protected these cells from lysis by CTLs, thus mimicking the inhibitory effect of IFN-gamma. This study provides evidence that CD94/NKG2A receptors play an important role in regulating T cell activity against tumors and shows that IFN-gamma modulation of target cells may shift the balance of triggering and inhibitory signals to T cells, turning off their cytolytic activity.

Original publication




Journal article


The Journal of clinical investigation

Publication Date





1515 - 1523


Immune and Gene Therapy Laboratory, Cancer Center Karolinska, Department of Oncology and Pathology, Stockholm, Sweden.


T-Lymphocytes, Cytotoxic, Tumor Cells, Cultured, Humans, Ovarian Neoplasms, Protein Sorting Signals, Lectins, C-Type, Receptors, Immunologic, Recombinant Proteins, Antigens, CD, Histocompatibility Antigens Class I, HLA-A Antigens, HLA-A2 Antigen, HLA Antigens, Signal Transduction, Cytotoxicity, Immunologic, Female, Interferon-gamma, NK Cell Lectin-Like Receptor Subfamily D, Receptors, Natural Killer Cell, NK Cell Lectin-Like Receptor Subfamily C, HLA-G Antigens, HLA-A11 Antigen